Relmada Therapeutics (RLMD) Insider Trading & Ownership $1.53 -0.12 (-7.27%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$1.54 +0.00 (+0.33%) As of 09/19/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Relmada Therapeutics (NASDAQ:RLMD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage20.70%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$286.33KNumber OfInsiders Selling(Last 12 Months)0 Get RLMD Insider Trade Alerts Want to know when executives and insiders are buying or selling Relmada Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RLMD Insider Buying and Selling by Quarter Relmada Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/20/2025Maged ShenoudaCFOBuy60,000$0.52$31,200.00 5/19/2025Maged ShenoudaCFOBuy90,000$0.49$44,100.00 5/16/2025Chuck EnceInsiderBuy228,961$0.45$103,032.45 5/16/2025Maged ShenoudaCFOBuy50,000$0.44$22,000.00 5/16/2025Paul Edward KellyCOOBuy200,000$0.43$86,000.00 (Data available from 1/1/2013 forward) RLMD Insider Trading Activity - Frequently Asked Questions Who is on Relmada Therapeutics' Insider Roster? The list of insiders at Relmada Therapeutics includes Cedric O'gorman, Charles J Casamento, Chuck Ence, Maged Shenouda, Paul Edward Kelly, and Sergio Traversa. Learn more on insiders at RLMD. What percentage of Relmada Therapeutics stock is owned by insiders? 20.70% of Relmada Therapeutics stock is owned by insiders. Learn more on RLMD's insider holdings. Which Relmada Therapeutics insiders have been buying company stock? The following insiders have purchased RLMD shares in the last 24 months: Charles J Casamento ($33,280.00), Chuck Ence ($159,147.45), Maged Shenouda ($256,681.20), Paul Edward Kelly ($86,000.00), and Sergio Traversa ($531,183.13). How much insider buying is happening at Relmada Therapeutics? Insiders have purchased a total of 872,437 RLMD shares in the last 24 months for a total of $1,066,291.78 bought. Relmada Therapeutics Key ExecutivesDr. Sergio Traversa M.B.A. (Age 64)Pharm.D., CEO & Director Compensation: $1.79MMr. Maged S. Shenouda M.B.A. (Age 60)R.Ph., Chief Financial Officer Compensation: $1.01MMr. Charles S. Ence CPA (Age 59)M.B.A., Chief Accounting & Compliance Officer Compensation: $995.03kDr. Paolo Manfredi M.D. (Age 62)Ph.D., Chief Scientific Officer Ms. Gina DiGuglielmoVP & Head of Clinical OperationsDr. Marco Pappagallo M.D. (Age 65)Chief Clinical Officer Mr. John HixonHead of CommercialDr. Andrew CutlerSenior Clinical Development AdvisorDr. Richard M. Mangano (Age 74)Consultant More Insider Trading Tools from MarketBeat Related Companies Vor Biopharma Insider Trades Entrada Therapeutics Insider Trades Tenaya Therapeutics Insider Trades SELLAS Life Sciences Group Insider Trades C4 Therapeutics Insider Trades Journey Medical Insider Trades Aardvark Therapeutics Insider Trades Black Diamond Therapeutics Insider Trades Scilex Insider Trades Neoleukin Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles $100 Million Buyback in Upwork Stock Follows a Strong Quarter Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in Outlook This page (NASDAQ:RLMD) was last updated on 9/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relmada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relmada Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RLMD Stock Alerts